Revel Pharmaceuticals Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Revel Pharmaceuticals's estimated annual revenue is currently $697.5k per year.(i)
  • Revel Pharmaceuticals's estimated revenue per employee is $77,500

Employee Data

  • Revel Pharmaceuticals has 9 Employees.(i)
  • Revel Pharmaceuticals grew their employee count by 80% last year.

Revel Pharmaceuticals's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head Enzyme EngineeringReveal Email/Phone
3
Research Associate IIReveal Email/Phone
4
Research Associate IIReveal Email/Phone
5
Scientist IIReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Revel Pharmaceuticals?

Revel Pharmaceuticals is a biotechnology commercializing therapeutic enzymes to degrade age associated molecule damage. We are targeting pathological age associated compounds known as Advanced Glycation End Products (AGEs) which build up on long lived proteins like collagen. AGE accumulation is implicated in multiple diseases of aging, thus Revel Pharmaceuticals is strategically position to develop therapeutics across multiple indications.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$697.5k

Revenue (est)

80%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.2M90%$24.7M
#2
$0.1M9-36%N/A
#3
$7.5M9-18%N/A
#4
$0.7M9N/AN/A
#5
$0.1M9-25%N/A